Literature DB >> 12923053

Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation.

Sunhwa Kim1, Takako Koga, Miho Isobe, Britt E Kern, Taeko Yokochi, Y Eugene Chin, Gerard Karsenty, Tadatsugu Taniguchi, Hiroshi Takayanagi.   

Abstract

Bone remodeling is central to maintaining the integrity of the skeletal system, wherein the developed bone is constantly renewed by the balanced action of osteoblastic bone formation and osteoclastic bone resorption. In the present study, we demonstrate a novel function of the Stat1 transcription factor in the regulation of bone remodeling. In the bone of the Stat1-deficient mice, excessive osteoclastogenesis is observed, presumably caused by a loss of negative regulation of osteoclast differentiation by interferon (IFN)-beta. However, the bone mass is unexpectedly increased in these mice. This increase is caused by excessive osteoblast differentiation, wherein Stat1 function is independent of IFN signaling. Actually, Stat1 interacts with Runx2 in its latent form in the cytoplasm, thereby inhibiting the nuclear localization of Runx2, an essential transcription factor for osteoblast differentiation. The new function of Stat1 does not require the Tyr 701 that is phosphorylated when Stat1 becomes a transcriptional activator. Our study provides a unique example in which a latent transcription factor attenuates the activity of another transcription factor in the cytoplasm, and reveals a new regulatory mechanism in bone remodeling.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12923053      PMCID: PMC196253          DOI: 10.1101/gad.1119303

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  46 in total

Review 1.  Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.

Authors:  John J O'Shea; Massimo Gadina; Robert D Schreiber
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 2.  Reaching a genetic and molecular understanding of skeletal development.

Authors:  Gerard Karsenty; Erwin F Wagner
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

Review 3.  RUNX transcription factors as key targets of TGF-beta superfamily signaling.

Authors:  Yoshiaki Ito; Kohei Miyazono
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

4.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

5.  Recombinant human bone morphogenetic protein induces bone formation.

Authors:  E A Wang; V Rosen; J S D'Alessandro; M Bauduy; P Cordes; T Harada; D I Israel; R M Hewick; K M Kerns; P LaPan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  SHP-2 is a dual-specificity phosphatase involved in Stat1 dephosphorylation at both tyrosine and serine residues in nuclei.

Authors:  Tong R Wu; Y Kate Hong; Xu-Dong Wang; Mike Y Ling; Ana M Dragoi; Alicia S Chung; Andrew G Campbell; Zhi-Yong Han; Gen-Sheng Feng; Y Eugene Chin
Journal:  J Biol Chem       Date:  2002-09-22       Impact factor: 5.157

Review 7.  Runx2, a multifunctional transcription factor in skeletal development.

Authors:  Toshihisa Komori
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

8.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.

Authors:  F Rousseau; J Bonaventure; L Legeai-Mallet; A Pelet; J M Rozet; P Maroteaux; M Le Merrer; A Munnich
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

Review 9.  Signaling crosstalk between RANKL and interferons in osteoclast differentiation.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Tadatsugu Taniguchi
Journal:  Arthritis Res       Date:  2002-05-09

10.  Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.

Authors:  A Yamaguchi; T Katagiri; T Ikeda; J M Wozney; V Rosen; E A Wang; A J Kahn; T Suda; S Yoshiki
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

View more
  88 in total

1.  ChIP Display: novel method for identification of genomic targets of transcription factors.

Authors:  Artem Barski; Baruch Frenkel
Journal:  Nucleic Acids Res       Date:  2004-07-13       Impact factor: 16.971

Review 2.  Building strong bones: molecular regulation of the osteoblast lineage.

Authors:  Fanxin Long
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

Review 3.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

Review 4.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

5.  Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein.

Authors:  Claire K Inman; Na Li; Paul Shore
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation.

Authors:  Keizo Nishikawa; Tomoki Nakashima; Shu Takeda; Masashi Isogai; Michito Hamada; Ayako Kimura; Tatsuhiko Kodama; Akira Yamaguchi; Michael J Owen; Satoru Takahashi; Hiroshi Takayanagi
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

Review 7.  Signaling and transcriptional regulation in osteoblast commitment and differentiation.

Authors:  Wei Huang; Shuying Yang; Jianzhong Shao; Yi-Ping Li
Journal:  Front Biosci       Date:  2007-05-01

Review 8.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

9.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

10.  RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.

Authors:  Rajeev K Boregowda; Oyenike O Olabisi; Walid Abushahba; Byeong-Seon Jeong; Keneshia K Haenssen; Wenjin Chen; Marina Chekmareva; Ahmed Lasfar; David J Foran; James S Goydos; Karine A Cohen-Solal
Journal:  Cancer Lett       Date:  2014-03-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.